Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Jeremy B Wingard,1 Darcie AP Delzell,2 Nathan V Houlihan,2 Jonathan Lin,2 Jon P Gieser1 1Wheaton Eye Clinic, Wheaton, IL 60187, USA; 2Mathematics and Computer Science Department, Wheaton College, Wheaton, IL, 60187, USACorrespondence: Jeremy B WingardWheaton Eye Clinic, 2015 N. Main Street, Wheaton,...
Guardado en:
Autores principales: | Wingard JB, Delzell DAP, Houlihan NV, Lin J, Gieser JP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bd57ea1c0f8344c38c7dfa48bd94ad6c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment Course of Patients with Exudative Age-Related Macular Degeneration Using Ocular Hypotensives
por: Modjtahedi BS, et al.
Publicado: (2020) -
Dietary Antioxidants in Age-Related Macular Degeneration and Glaucoma
por: Jacek Dziedziak, et al.
Publicado: (2021) -
Management of neovascular age-related macular degeneration: Taiwan expert consensus
por: Ling Yeung, et al.
Publicado: (2021) -
Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi NA, et al.
Publicado: (2019) -
Vision Recovery Velocity, Momentum and Acceleration: Advanced Vitreoretinal Analytics as Measure of Treatment Efficacy for Neovascular Age-Related Macular Degeneration
por: Almeida DRP, et al.
Publicado: (2021)